ATE540691T1 - Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung - Google Patents

Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Info

Publication number: ATE540691T1
Authority: AT; Austria
Prior art keywords: vaccine formulation; parenteral administration; excipient; allergen; allergen composition
Prior art date: 2007-03-28

Application number

AT08153545T

Other languages

English (en)

Inventor

Eike Gunther Wuestenberg

Original Assignee

Alk Abello As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-28

Filing date

2008-03-28

Publication date

2012-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38093538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE540691(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-28 Application filed by Alk Abello As filed Critical Alk Abello As

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE540691T1 publication Critical patent/ATE540691T1/de

Links

239000000203 mixture Substances 0.000 title abstract 6
238000009472 formulation Methods 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 3
238000007911 parenteral administration Methods 0.000 title abstract 2
239000000546 pharmaceutical excipient Substances 0.000 title 1
239000013566 allergen Substances 0.000 abstract 4
206010020751 Hypersensitivity Diseases 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000001932 seasonal effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

AT08153545T 2007-03-28 2008-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung ATE540691T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90731707P	2007-03-28	2007-03-28
EP07105094A EP1974745B1 (de)	2007-03-28	2007-03-28	Verwendung einer hilfsstoffhaltigen Impfstoffformulierung für subkutane Verabreichung

Publications (1)

Publication Number	Publication Date
ATE540691T1 true ATE540691T1 (de)	2012-01-15

Family

ID=38093538

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT07105094T ATE522228T1 (de)	2007-03-28	2007-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung
AT08153545T ATE540691T1 (de)	2007-03-28	2008-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT07105094T ATE522228T1 (de)	2007-03-28	2007-03-28	Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung

Country Status (5)

Country	Link
US (1)	US20120141536A1 (de)
EP (1)	EP1974745B1 (de)
AT (2)	ATE522228T1 (de)
DK (2)	DK1974745T3 (de)
ES (2)	ES2370043T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2908857B1 (de) *	2012-10-19	2017-08-09	Hal Allergy Holding B.V.	Zusammensetzungen zur immuntherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4031199A (en)	1972-12-11	1977-06-21	Merck Patent Gesellschaft Mit Beschrankter Haftung	Process for the production of allergen-containing extracts
CA2554337A1 (en) *	2004-02-06	2005-08-25	Greer Laboratories, Inc.	Methods and compositions for dosing of allergens
CA2556557A1 (en)	2004-02-26	2005-09-09	Alk Abello A/S	Method of evaluating the therapeutic potential of a vaccine for mucosal administration
US20060115499A1 (en) *	2004-09-27	2006-06-01	Alk-Abello A/S	Liquid allergy vaccine formulation for oromucosal administration

2007
- 2007-03-28 DK DK07105094.2T patent/DK1974745T3/da active
- 2007-03-28 ES ES07105094T patent/ES2370043T3/es active Active
- 2007-03-28 AT AT07105094T patent/ATE522228T1/de not_active IP Right Cessation
- 2007-03-28 EP EP07105094A patent/EP1974745B1/de active Active
2008
- 2008-03-28 US US12/593,263 patent/US20120141536A1/en not_active Abandoned
- 2008-03-28 ES ES08153545T patent/ES2380172T3/es active Active
- 2008-03-28 AT AT08153545T patent/ATE540691T1/de active
- 2008-03-28 DK DK08153545.2T patent/DK1974746T3/da active

Also Published As

Publication number	Publication date
EP1974745A1 (de)	2008-10-01
EP1974745B1 (de)	2011-08-31
ATE522228T1 (de)	2011-09-15
DK1974745T3 (da)	2011-11-28
ES2380172T3 (es)	2012-05-09
US20120141536A1 (en)	2012-06-07
ES2370043T3 (es)	2011-12-12
DK1974746T3 (da)	2012-04-10

Similar Documents

Publication	Publication Date	Title
CY1122466T1 (el)	2020-10-14	Σκευασμα αντισωματος αντι il-17ra και θεραπευτικα σχηματα για την αγωγη της ψωριασης
CY1123476T1 (el)	2022-03-24	Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
BR112013029256A8 (pt)	2018-01-16	combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
CO6670520A2 (es)	2013-05-15	Lactmas sustituidas con piperidinio como moduladores de gpr119
ECSP10010216A (es)	2010-07-30	4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
NI201300074A (es)	2013-12-17	Novedosos derivados de azabencimidazol cíclico útiles como agentes antidiabéticos.
BR112012027759A2 (pt)	2017-08-15	Conjugados de peptídeos de agonistas de receptores glp-1 e gastrina e seu uso
UA117570C2 (uk)	2018-08-27	Спосіб лікування діабету або діабету, спричиненого ожирінням, або ускладнень при діабеті
ECSP12012310A (es)	2012-12-28	5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BRPI1009637A2 (pt)	2019-04-30	composto, composição e uso de um composto
BR112014010590A2 (pt)	2017-05-02	18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
ECSP11011082A (es)	2011-09-30	Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos
BR112015012366A2 (pt)	2017-07-11	antagonistas de cxcr7
BR112014027117A2 (pt)	2017-06-27	derivados de pirazol aminopirimidina como moduladores de lrrk2 para uso no tratamento de doença de parkinson
BR112012013487A2 (pt)	2017-10-03	Composições de amantadina e métodos de uso
CU20100111A7 (es)	2011-10-14	4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
BR112012027197A2 (pt)	2016-07-19	combinação ou composição farmacêutica, seu uso, kit, e compostos para tratamento de doenças oncológicas e fibróticas
SMT201500190B (it)	2015-09-07	Composizioni comprendenti un anticorpo a p2-specifico o un suo frammento per l'uso nel trattamento del diabete, intolleranza al glucosio o insulino-resistenza indotta dall'obesita'
WO2013028818A8 (en)	2013-09-19	Pyrimido- pyridazinone compounds and use thereof
MX2020005738A (es)	2021-08-13	Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida.
BR112012030482A2 (pt)	2016-08-09	tratamento de diabetes tipo 2
BRPI0710405B8 (pt)	2021-05-25	comprimido de racecadotril, processo de preparação de um comprimido de racecadotril e uso de racecadotril
BRPI0905687A2 (pt)	2015-07-07	"composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto"
NI201100117A (es)	2012-06-13	Antagonistas de 4 -- azetidinil - 1 - heteroaril - ciclohexanol del ccr2.
ECSP077340A (es)	2007-04-26	Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa